BMO Capital Downgrades Clinical Data (CLDA) to Market Perform
Tweet Send to a Friend
BMO Capital downgraded Clinical Data (NASDAQ: CLDA) from Outperform to ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
